Methods of stimulating cartilage formation

Procedes de stimulation de la formation de cartilage


The disruption of the murine ROR2 gene leads to profound skeletal abnormalities, with essentially all endochondrally derived bones foreshortened and/or misshapen, albeit to differing degrees. ROR2 is selectively expressed in the chondrocytes of all developing cartilage anlagen, where it plays a critical role during initial growth and patterning, as well as subsequently in the proliferating chondrocytes of mature growth plates, where it is required for normal expansion. As ROR2 appears to play a critical role in cartilage formation and it may be useful in developing therapeutic strategies to treat diseases of cartilage such as osteoarthritis.
La rupture du gène murin ROR2 conduit à de profondes anomalies du squelette, telles que des raccourcissements et/ou des déformations observés dans presque tous les os d'origine endochondrale, bien qu'à des degrés différents. ROR2 est exprimé sélectivement dans les chondrocytes de tout primordium de cartilage, où il joue un rôle critique au cours de la croissance initiale et de la structuration fonctionnelle, ainsi qu'ultérieurement dans les chondrocytes proliférants de cartilages de conjugaison à maturité, où il est nécessaire à un développement normal. ROR2 semble jouer un rôle critique dans la formation du cartilage et il peut s'avérer utile au développement de stratégies thérapeutiques destinées au traitement de maladies du cartilage telles que l'arthrose.




Download Full PDF Version (Non-Commercial Use)

Patent Citations (1)

    Publication numberPublication dateAssigneeTitle
    US-5843749-ADecember 01, 1998Regeneron Pharmaceuticals, Inc.Ehk and Ror tyrosine kinases

NO-Patent Citations (9)

    DECHIARA THOMAS M ET AL: "Ror2, encoding a receptor-like tyrosine kinase, is required for cartilage and growth plate development." NATURE GENETICS, vol. 24, no. 3, March 2000 (2000-03), pages 271-274, XP002177001 ISSN: 1061-4036
    LEGEAI-MALLET LAURENCE ET AL: "Fibroblast growth factor receptor 3 mutations promote apoptosis but do not alter chondrocyte proliferation in thanatophoric dysplasia." JOURNAL OF BIOLOGICAL CHEMISTRY, vol. 273, no. 21, 22 May 1998 (1998-05-22), pages 13007-13014, XP002928577 ISSN: 0021-9258
    LUNSTRUM GREGORY P ET AL: "Chondrocyte differentiation in a rat mesenchymal cell line." JOURNAL OF HISTOCHEMISTRY AND CYTOCHEMISTRY, vol. 47, no. 1, January 1999 (1999-01), pages 1-6, XP002928578 ISSN: 0022-1554
    OISHI ISAO ET AL: "A novel Drosophila receptor tyrosine kinase expressed specifically in the nervous system. Unique structural features and implication in developmental signaling." JOURNAL OF BIOLOGICAL CHEMISTRY, vol. 272, no. 18, 1997, pages 11916-11923, XP002177000 ISSN: 0021-9258
    OLDRIDGE MICHAEL ET AL: "Dominant mutations in ROR2, encoding an orphan receptor tyrosine kinase, cause brachydactyly type B." NATURE GENETICS, vol. 24, no. 3, March 2000 (2000-03), pages 275-278, XP002177002 ISSN: 1061-4036 cited in the application
    SALDANHA JOSE ET AL: "Identification of a Frizzled-like cysteine rich domain in the extracellular region of developmental receptor tyrosine kinases." PROTEIN SCIENCE, vol. 7, no. 7, July 1998 (1998-07), pages 1632-1635, XP001020349 ISSN: 0961-8368
    TAKEUCHI SHIGETO ET AL: "Mouse Ror2 receptor tyrosine kinase is required for the heart development and limb formation." GENES TO CELLS., vol. 5, no. 1, January 2000 (2000-01), pages 71-78, XP002176999 ISSN: 1356-9597
    VORTKAMP ANDREA ET AL: "Regulation of rate of cartilage differentiation by Indian hedgehog and PTH-related protein." SCIENCE (WASHINGTON D C), vol. 273, no. 5275, 1996, pages 613-622, XP001024073 ISSN: 0036-8075
    WEIR E ET AL: "Targeted overexpression of parathyroid hormone-related peptide in chondrocytes causes chondrodysplasia and delayed endochondral bone formation" PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF USA, NATIONAL ACADEMY OF SCIENCE. WASHINGTON, US, vol. 93, September 1996 (1996-09), pages 10240-10245, XP002105139 ISSN: 0027-8424 cited in the application

Cited By (5)

    Publication numberPublication dateAssigneeTitle
    JP-2006524508-ANovember 02, 2006ワイスWyeth骨関連の活性を調節する新規な方法
    WO-2004094641-A2November 04, 2004WyethNouveau procede de modulation de l'activite liee a l'os
    WO-2004094641-A3March 10, 2005Wyeth Corp, Peter Van Nest Bodine, Julia BilliardNouveau procede de modulation de l'activite liee a l'os
    WO-2007098198-A2August 30, 2007WyethModulation of bone formation
    WO-2007098198-A3March 13, 2008Wyeth Corp, Julia Billiard, Yan LiuModulation of bone formation